Literature DB >> 17696994

Brain gene expression correlates with changes in behavior in the R6/1 mouse model of Huntington's disease.

A Hodges1, G Hughes, S Brooks, L Elliston, P Holmans, S B Dunnett, L Jones.   

Abstract

Huntington's disease (HD) is an inherited neurodegeneration that causes a severe progressive illness and early death. Several animal models of the disease have been generated carrying the causative mutation and these have shown that one of the earliest molecular signs of the disease process is a substantial transcriptional deficit. We examined the alterations in brain gene expression in the R6/1 mouse line over the course of the development of phenotypic signs from 18 to 27 weeks. Changes in R6/1 mice were similar to those previously reported in R6/2 mice, and gene ontology analysis shows that pathways related to intracellular and electrical signaling are altered among downregulated genes and lipid biosynthesis and RNA processes among upregulated genes. The R6/1 mice showed deficits in rotarod performance, locomotor activity and exploratory behavior over the time-course. We have correlated the alterations in gene expression with changes in behavior seen in the mice and find that few alterations in gene expression correlate with all behavioral changes but rather that different subsets of the changes are uniquely correlated with one behavior only. This indicates that multiple behavioral tasks assessing different behavioral domains are likely to be necessary in therapeutic trials in mouse models of HD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17696994     DOI: 10.1111/j.1601-183X.2007.00350.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  20 in total

Review 1.  Huntington's disease: can mice lead the way to treatment?

Authors:  Zachary R Crook; David Housman
Journal:  Neuron       Date:  2011-02-10       Impact factor: 17.173

Review 2.  Choosing an animal model for the study of Huntington's disease.

Authors:  Mahmoud A Pouladi; A Jennifer Morton; Michael R Hayden
Journal:  Nat Rev Neurosci       Date:  2013-10       Impact factor: 34.870

3.  Dysregulation of dopamine receptor D2 as a sensitive measure for Huntington disease pathology in model mice.

Authors:  Zachary R Crook; David E Housman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-23       Impact factor: 11.205

4.  HYPK coordinates degradation of polyneddylated proteins by autophagy.

Authors:  Debasish Kumar Ghosh; Akash Ranjan
Journal:  Autophagy       Date:  2021-11-26       Impact factor: 13.391

5.  Tracking brain palmitoylation change: predominance of glial change in a mouse model of Huntington's disease.

Authors:  Junmei Wan; Jeffrey N Savas; Amy F Roth; Shaun S Sanders; Roshni R Singaraja; Michael R Hayden; John R Yates; Nicholas G Davis
Journal:  Chem Biol       Date:  2013-11-07

6.  A Drosophila model of Huntington disease-like 2 exhibits nuclear toxicity and distinct pathogenic mechanisms from Huntington disease.

Authors:  Megan Krench; Richard W Cho; J Troy Littleton
Journal:  Hum Mol Genet       Date:  2016-06-10       Impact factor: 6.150

7.  Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease.

Authors:  Lan Lin; Juw Won Park; Shyam Ramachandran; Yida Zhang; Yu-Ting Tseng; Shihao Shen; Henry J Waldvogel; Maurice A Curtis; Richard L M Faull; Juan C Troncoso; Olga Pletnikova; Christopher A Ross; Beverly L Davidson; Yi Xing
Journal:  Hum Mol Genet       Date:  2016-07-04       Impact factor: 6.150

8.  Sex-dependent changes in social behaviors in motor pre-symptomatic R6/1 mice.

Authors:  Susanna Pietropaolo; Pauline Delage; Sebastien Cayzac; Wim E Crusio; Yoon H Cho
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

9.  Promoters are differentially sensitive to N-terminal mutant huntingtin-mediated transcriptional repression.

Authors:  Matthew Hogel; Robert B Laprairie; Eileen M Denovan-Wright
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

Review 10.  Mouse models of polyglutamine diseases: review and data table. Part I.

Authors:  Maciej Figiel; Wojciech J Szlachcic; Pawel M Switonski; Agnieszka Gabka; Wlodzimierz J Krzyzosiak
Journal:  Mol Neurobiol       Date:  2012-09-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.